Tenet Fintech Appoints Liang Qui to Head Business Hub Development-February 2024-www.financetom.com

Tenet Fintech Appoints Liang Qui to Head Business Hub Development

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Tenet Fintech Appoints Liang Qui to Head Business Hub Development

Nov 3, 2024 11:32 AM

08:35 AM EDT, 10/25/2024 (MT Newswires) -- Tenet Fintech Group ( PKKFF ) appointed Liang Qiu to head the global development of the Business Hub.

Qiu, a software engineer and CEO of Tenet's Chinese operations, will bring the China and Canada platforms of the business hub into a single global business development network for small and medium sized business owners, the company said.

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： Cannabis firm Canopy's Q1 revenue beats estimates

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Cannabis firm Canopy's Q1 revenue beats estimates

Aug 8, 2025

(Corrects headline, overview and key details table to say Q1 revenue beat expectations; corrects revenue figure in key details) Overview * Canopy Growth ( CGC ) fiscal Q1 revenue rises 9% yr/yr, beating analyst expectations * Gross margin declines to 25% from 35% due to product mix shift * SG&A expenses down 21% yr/yr, achieving C$17 mln in cost savings...

Repare Therapeutics Q2 net loss narrows to $16.7 mln

Aug 8, 2025

Overview * Repare Therapeutics ( RPTX ) Q2 net loss narrows to $16.7 mln from $34.8 mln last year * Co entered worldwide licensing agreement with Debiopharm for lunresertib * Exploring strategic alternatives to maximize shareholder value Outlook * Company expects Q4 2025 data from LIONS and POLAR trials * Repare exploring strategic alternatives to maximize shareholder value * Company...

Medical device maker Surmodics's Q3 revenue dips 3%, FY guidance raised

Aug 8, 2025

Overview * Surmodics ( SRDX ) fiscal Q3 revenue dips 3% yr/yr to $29.6 mln * Adjusted EBITDA rises to $3.4 mln, improving from $1.6 mln last year * Co raises fiscal 2025 revenue guidance, reflecting strong Q3 performance Outlook * Surmodics ( SRDX ) raises fiscal 2025 revenue guidance to $116.5 mln-$118.5 mln * Company expects fiscal 2025 GAAP...